We valued an asset across a range of contingencies to support partnering discussions

Client challenge

CEO, CFO, Business development function for development stage biotech

Required defensible and independent valuation of their principal asset in order to frame deal negotiation


InterPhase Consult solution

We provided a full research and analysis programme incorporating epidemiology, pricing, market analysis, and competitive analysis across a range of scenarios

We built in flexibility so that our client could benefit from our model as their product and the market developed


Result

Powerful and flexible tool that builds the business case for investment, providing patient flows, market shares, revenues, costs and valuations

A solution used across the organisation to strengthen deal-making, evaluate scenarios and support strategic decision-making

A solution that empowered our client to represent the best interests of their shareholders and understand the level of commitment required from potential partners